title: [Comparison of hypersensitivity to branded and generic paclitaxel injections in rats].
abstract: The use of injectable generic antineoplastic agents has been increasing. Few studies have compared the quality and adverse reactions of generic and branded antineoplastic agents; and therefore, generic agents have not gained wide acceptance. Paclitaxel injections, which are used for treating solid cancers, are being marketed by some companies in Japan. The degree of hypersensitive reactions to these drugs may vary because of the differences in chemical properties of the polyoxyethylene castor oil that is used as a solvent in the paclitaxel preparations. Therefore, we investigated the incidence of pulmonary edema occurring as a hypersensitive reaction in rats administered branded and generic paclitaxel injections. Moreover, we compared the chemical properties of these preparations. We found that the pH of branded and generic paclitaxel preparations diluted with saline was different. This difference in pH may be attributed to a difference in chemical properties from the additive. We observed no significant differences in pulmonary vascular permeability, arterial partial pressure of oxygen, or leakage of protein in the pulmonary alveolus, between paclitaxel preparations administered to rats. These results suggest that both paclitaxel preparations induced pulmonary edema of a similar level in rats, irrespective of the differences in their chemical properties.
authors.affiliation: Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Japan.
authors.forename: Takeshi
authors.initials: T
authors.lastname: Goromaru
authors.forename: Naofumi
authors.initials: N
authors.lastname: Morita
authors.forename: Yuki
authors.initials: Y
authors.lastname: Hase
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Ochi
authors.forename: Yoshitake
authors.initials: Y
authors.lastname: Shinohara
authors.forename: Kojiro
authors.initials: K
authors.lastname: Takahashi
authors.forename: Seiji
authors.initials: S
authors.lastname: Eto
mesh_terms: D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects*; D004342:Drug Hypersensitivity; D016568:Drugs, Generic / Q000008:administration & dosage / Q000009:adverse effects*; D006863:Hydrogen-Ion Concentration; D007267:Injections; D008297:Male; D009997:Osmotic Pressure; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects*; D011654:Pulmonary Edema / Q000139:chemically induced*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D016568:Drugs, Generic; D017239:Paclitaxel